BioTuesdays: Opexa is Personalizing the Treatment of Autoimmune Disease
Neurology Reviews:Regulation May Be Impaired in Patients with Secondary Progressive MS
Radio Interview:OneMedRadio interviews Neil Warma, President and CEO of Opexa Therapeutics
New York Financial Press:Opexa Therapeutics - Neil Warma
First Quarter Earnings Call - 2013
FOX News: "New Therapy Could Battle Autoimmune Diseases"